Your session is about to expire
← Back to Search
Albuterol for Respiratory Muscle Weakness in Spinal Cord Injury
Study Summary
This trial is testing whether 16 weeks of Albuterol can help improve respiratory strength and cough effectiveness for people with Spinal Cord Injury.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have an overactive thyroid.I have a lung condition or had a lung infection in the last 3 months.I do not have uncontrolled high blood pressure or heart disease.You need a ventilator to help you breathe.I have a history of epilepsy or seizures.I use or might be using supplements or medications that boost muscle growth.My spinal cord injury is between my upper and middle back.I am currently on corticosteroids.You have smoked or been around smoke in the past year.My breathing strength is below the normal range.I am currently on monoamine oxidase inhibitors or tricyclic antidepressants.I am currently using a beta-2 adrenergic agonist medication.You have had serious injuries to your chest in the past.My spinal cord injury is between my neck and upper back.You are allergic to albuterol or any of its ingredients.I am currently taking antidepressants.You have had asthma in the past.I have had a spinal cord injury for over a year.I am between 18 and 80 years old.
- Group 1: Active Oral Beta-2
- Group 2: Placebo
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the FDA authorized Active Oral Beta-2 for utilization?
"Data from prior clinical trials suggests that Active Oral Beta-2 is safe enough to have earned a rating of 3 on our scale. This treatment has already been approved for public use, signifying Phase 4 status."
What is the capacity of enrolled participants in this research endeavor?
"Currently, this trial is not recruiting at present. Initially posted on June 1st 2016 and last edited November 8th 2022, interested patients should look towards the 423 studies actively seeking participants with asthenia or 17 trials for Active Oral Beta-2 which are currently accepting volunteers."
Are there any opportunities available to participate in this experiment?
"Contrary to expectations, clinicaltrials.gov does not showcase that this study is seeking for participants; the trial was posted on June 1st 2016 and last updated November 8th 2022. Nevertheless, there are 440 other active trials currently recruiting patients."
Is there a specific demographic suitable for enrollment in this research endeavor?
"This medical trial is recruiting up to 5 individuals aged 18-80 years old with asthenia, who also meet the following conditions: male or female tetraparetic patients (C3 - C8) or high paraplegic patients (T1 - T6), and males with a maximal inspiratory pressure of less than 90 cmH2O, or females with an MIP below 65 cmH2O."
Is the age requirement for this research limited to individuals under 25?
"The age range for this medical experiment is between 18 and 80 years old as stated in the trials eligibility criteria."
What type of medical conditions is Active Oral Beta-2 typically employed for?
"The common application for Active Oral Beta-2 is to alleviate exercise-induced bronchospasm, however it can also be prescribed as a treatment option for various other ailments such as respiratory tract infections and bronchodilator agents."
Has Active Oral Beta-2 been the subject of other research investigations?
"Currently, 17 scientific trials are underway to study the effects of Active Oral Beta-2. None of these studies have advanced to phase 3 yet; however they are being conducted at 75 sites across San Francisco, California."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger